{"url_path":"/sec/ixhl/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1873875/0001213900-26-057227-index.html","accession_number":"0001213900-26-057227","cik":"0001873875","ticker":"IXHL","issuer_name":"Incannex Healthcare Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1873875/0001213900-26-057227-index.html","primary_entity_key":"0001873875","primary_entity_name":"Incannex Healthcare Inc."},"word_count":45,"has_tables":true,"body_markdown":"Item\n5. Other Information\n\n \n\nRule\n10b5-1 trading arrangements\n\n \n\nDuring\nthe three months ended March 31, 2026, none of our directors or officers adopted or terminated “Rule 10b5-1 trading arrangement”\nor “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K."}